Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

NCT04083534

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Regeneron Study Site Indianapolis, Indiana, United States
  • Regeneron Study Site Ann Arbor, Michigan, United States
  • Regeneron Study Site Rochester, Minnesota, United States
  • Regeneron Study Site New York, United States
View Trial Details
Completed

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

NCT01231412

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT01816971

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana Farber Boston, Massachusetts, United States
  • Washington University in St Louis St Louis, Missouri, United States
  • Sarah Cannon Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

NCT02719613

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 0020 Tucson, Arizona, United States
  • Local Institution - 0017 Bakersfield, California, United States
  • Local Institution - 0022 Fountain Valley, California, United States
  • Local Institution - 0016 West Hollywood, California, United States
View all 41 locations
View Trial Details

Related conditions